Cresco Labs Inc.
CL
CNSX
| 06/30/2025 | 03/31/2025 | 12/31/2024 | 09/30/2024 | 06/30/2024 | |
|---|---|---|---|---|---|
| Revenue | 677.35M | 697.32M | 715.76M | 726.35M | 734.82M |
| Total Other Revenue | -- | -- | -- | -- | -- |
| Total Revenue | 677.35M | 697.32M | 715.76M | 726.35M | 734.82M |
| Cost of Revenue | 345.72M | 354.93M | 359.89M | 360.10M | 370.67M |
| Gross Profit | 331.63M | 342.38M | 355.87M | 366.26M | 364.15M |
| SG&A Expenses | 221.49M | 224.50M | 222.15M | 220.30M | 224.89M |
| Depreciation & Amortization | 20.74M | 21.50M | 21.77M | 26.29M | 26.53M |
| Other Operating Expenses | -- | -- | -- | -- | -- |
| Total Operating Expenses | 587.94M | 600.94M | 603.81M | 606.69M | 622.09M |
| Operating Income | 89.40M | 96.38M | 111.95M | 119.66M | 112.73M |
| Income Before Tax | 16.20M | -27.48M | -10.62M | -853.00K | -131.37M |
| Income Tax Expenses | 52.58M | 46.19M | 49.87M | 55.21M | 30.45M |
| Earnings from Continuing Operations | -36.38 | -73.67 | -60.49 | -56.06 | -161.81 |
| Earnings from Discontinued Operations | -- | -- | -- | -- | -- |
| Extraordinary Item & Accounting Change | -- | -- | -- | -- | -- |
| Minority Interest in Earnings | -9.30M | -10.01M | -13.95M | -11.37M | -10.65M |
| Net Income | -45.68M | -83.68M | -74.44M | -67.43M | -172.46M |
| EBIT | 89.40M | 96.38M | 111.95M | 119.66M | 112.73M |
| EBITDA | 143.34M | 153.05M | 171.05M | 185.10M | 178.54M |
| EPS Basic | -0.13 | -0.24 | -0.22 | -0.20 | -0.51 |
| Normalized Basic EPS | 0.03 | -0.07 | -0.05 | -0.03 | -0.04 |
| EPS Diluted | -0.13 | -0.24 | -0.22 | -0.20 | -0.51 |
| Normalized Diluted EPS | 0.03 | -0.07 | -0.05 | -0.03 | -0.04 |
| Average Basic Shares Outstanding | 1.40B | 1.39B | 1.38B | 1.37B | 1.36B |
| Average Diluted Shares Outstanding | 1.40B | 1.39B | 1.38B | 1.37B | 1.36B |
| Dividend Per Share | -- | -- | -- | -- | -- |
| Payout Ratio | -0.44% | -0.24% | -0.27% | -0.30% | -- |